We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ixico Plc | LSE:IXI | London | Ordinary Share | GB00BFXR4C20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 8.75 | 8.50 | 9.00 | 8.75 | 8.75 | 8.75 | 0.00 | 07:33:41 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
10/3/2014 14:02 | With the International alliance with VirtualScopics in place this should be heading back to £1.20 a share it was not so long ago. | bckttsim | |
13/1/2014 11:17 | see RNS Prof Hill MD of IXico speaking in China again with UK Minister of oF Health. I don't think he is there just to talk, is another deal in the offing ? await contract news and a share price jump | loobrush | |
20/12/2013 16:39 | I think you may be wrong in your assumption that its not worth chasing ,as you have pointed out with only a few shares being traded this exagerates the price movement, both up and down. However most investors have not cottoned on to what this company actually does and what the potential is. A visit to the IXICO website explains this in some detail and is very worthwhile, however this does not provide any financial projections of the three areas of their business. I am advised that this will be forthcoming in the new year. However, waiting until this is available or the company is anylised in the press or elsewhere may be unwise as the share price will take off again on any positive comment and you may miss the boat. | loobrush | |
20/12/2013 13:59 | I make it a 16.6 bagger at the mo Petcb1, if the 130p 10-bagger poster was correct, and that 16.6x could get bigger if the share price drops more:). But it's meaningless and I doubt if the poster was correct or at least, not for a long time. This spiked on hot air off the back of the Cameron China trip and the G8. I think it might do ok but not worth chasing too high at this stage, I hold a few for the long term. | paleje | |
20/12/2013 09:16 | please could someone check my maths..? If it was an "easy 10 bagger" when the price was 130p.. now it's an easy 15 bagger... right? | petecb1 | |
17/12/2013 10:35 | From latest RNS IXICO has now been awarded contracts by eight of the top fifteen global pharmaceutical companies Shows what the potential is here. | loobrush | |
17/12/2013 07:09 | Highlights · Successful integration of IXICO Technologies Limited and Phytopharm plc and renaming of the enlarged group as IXICO plc · Launch of Assessa, our proprietary platform to support timely and accurate diagnosis of dementia o Widened collaboration with InHealth Limited to provide Assessa and complementary services within the UK and Eire o Initial piloting of Assessa in a community setting in collaboration with partners · Memorandum of understanding signed with Beijing Union Medical and Pharmaceutical General Corporation during the UK trade mission to China following which IXICO has also been awarded its first contract for specialist drug development services with a Chinese pharmaceutical company · Awarded a new contract to provide clinical trials services by a top fifteen global pharmaceutical company with whom IXICO has not previously worked o Contract is for early phase clinical trial for an investigational drug for the treatment of mild to moderate Alzheimer's disease o IXICO has now been awarded contracts by eight of the top fifteen global pharmaceutical companies · IXICO's work in dementia recognised by Prime Minister David Cameron in his speech to the G8 Dementia Summit on 11 December 2013 · Awarded Stratified Medicine Grant by the Technology Strategy Board, the UK's innovation agency Financial Highlights · Revenue and expenses in line with budget with the operating loss reflecting planned increased investment to develop Assessa, the Company's diagnostic platform · Combined cash deposits of approximately £5.7 million as at 15 October 2013 of which an estimated £4.8 million available to the Company (following payment of certain Transaction costs and redundancy payments) | skinny | |
13/12/2013 11:45 | latest grant award is brilliant news. Cash is rolling in with half the companies value in by cash in hand valuing the whole business at only £9 million To find out more what the company is about look at this info on www.innovateuk.org/s They are finalising the design of the diagnostic kit to enable it to be used worldwide in conjunction with AstraZeneca and Imperial College plus other unnamed large company. See latest RNS They have global ambitions. Share price wont stay at these levels for long. | loobrush | |
12/12/2013 20:33 | Details of the product they have launched can be found here. www.myassessa.com Expect more contract news soon. Short term traders will exit shortly and price will rise accordingly unless they get tipped and then rise will be very energetic as not too many shares in circulation. | loobrush | |
11/12/2013 13:20 | I'm sure we as a Co will benefit from this: Someone referred to "traders" earlier. Well I have my own holdings, but also have one open position (@52p)which I was going to close. But the more I think about the whole story here, from the Co situation in all respects, through to the whole issue of disease, the story from an investment point of view just seems better and better so I'm going to add that to my holdings. I truly think anyone getting in even now - or very soon - will be in on one of the best investments of the next few years. (More Inst are bound to pick up on this - post PYM - very soon). GLA. | gerhart | |
11/12/2013 10:37 | With no tax to pay on profits for some years by utilising losses from PYM. | vg2208 | |
11/12/2013 09:46 | from coldascheese on iii board "Researching more into and dementia and the other brain problems that there are I have only just understood how really big the problem is and what this will mean for IXICO. According to article in the Daily mail today(10 December) page 51, 25 billion has been spent on research into cures and treatments of DEMENTIA and ALZHEIMER'S and the amount is going to increase dramatically. Tomorrow sees the start of the G8 summit in London on this problem where all the experts from the worlds leading economies will meet to coordinate an action plan for tackling this. Professor Hill the chief exec of IXICO who recently signed the deal with the Chinese Academy of Medical Science will be in attendance. Tonight on NEWSNIGHT this summit meeting and the action required from it was discussed in more detail with the minister responsible advising that a great deal t more money was going to be spent on research into this problem. With Professor Hill and his team at IXICO being the only quoted company in this field and WORLD LEADERS at what the do in research IXICO will receive much greater publicity than of late and show what a truly great opportunity exists with this company and share price. They are already earning money and have over 8 million in the bank so are not like your usual cash hungry research/medical companies on multiple pe ratios valued at ten times the amount. I would also remind all about the company from their recent Aim Listing IXICO brings innovative technologies to those researching, diagnosing and treating serious diseases, especially dementia. Its technologies enable timely decision-making aimed at improving patient outcomes. IXICO was founded with a mission to translate image acquisition, management and analysis technology and know-how, which the founders had developed together, into commercial products. These target the expanding area of imaging to inform decision-making during drug development, especially for treatments for Alzheimer's Disease and other brain disorders. This has resulted in commercially successful products being launched in the clinical trials and experimental medicine markets and such products are now being readied for launch into the wider clinical diagnostic market to support the diagnosis of dementia Products ready for launch it says. Small holding PI's who have not understood the potential here have been selling today I would advise them to do bit more research as the potential of the company and what could come from this summit to the benefit of IXICO will be truly dramatic. The Chinese have recognized it-this share will be many multiples of todays price in a years time. " THIS HAS GOT TO BE AN OUSTANDING BUY AND I AM ADDING TO MY HOLDING | loobrush | |
11/12/2013 08:18 | G8 summit today on dementia. | geoff80 | |
11/12/2013 08:17 | IXI certainly into a topical subject. Dementia on Radio 4 now and last night on TV. Terry Pratchett on Newsnight with Jeremy Paxman. | geoff80 | |
11/12/2013 07:22 | With £132m available for dementia research, the timing here is spot on. Just hope that the traders don't arrive too soon. | ewads | |
11/12/2013 07:15 | IXICO announces launch of a decision-support tool for diagnosing dementia and widened collaboration with InHealth · Assessa helps healthcare professionals make fast and accurate diagnosis of dementia · InHealth and IXICO to provide access to Assessa selectively in the UK and Eire · IXICO piloting the use of Assessa in a community setting in a collaboration with partners | skinny | |
10/12/2013 08:25 | Expect more deals to announced during this meeting-hold on tight I believe this will really move up, still vastly undervalued | loobrush | |
10/12/2013 07:34 | Derek Hill, IXICO's CEO, will attend the G8 Global CEO Initiative on Alzheimer's disease on 12 December, 2013 | ewads | |
09/12/2013 20:48 | Ewads most paid much more for shares when PYM. Then after reverse takeover they did a 50:1 CONSOL! Two combined means there aren't/wont be for a while many loose shares so good for buyers now. Eventually there will be further placings. | eastend2 | |
09/12/2013 19:10 | Noticed that all trades are small volume. Is this because of the limited number available? | ewads | |
09/12/2013 11:01 | Thanks for the link Aisha. | gerhart | |
09/12/2013 10:23 | Todays price will look like pocket money in a years time still well undervalued and overlooked looks very likely you will get your money back Liberating Steptoe and could even be in profit. | loobrush | |
09/12/2013 10:06 | Blimey .. Bought in last week at 80p and almost immediately felt a bit of buyers remorse as it had already ran up from 50p few days before .Now I look at 145p and my remorse is that I didn't buy more at 80pFunny old game | malhashemi |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions